· acute, often fatal disease
· caused by exotoxins produced in Clostridia tetani infections
· characterised by generalised muscle rigidity and convulsions
· preventable with immunisation
· was major problem during wars
· annual world mortality now is 1 000 000
· prevalent in rural areas with poor hygiene and medical services
· highest incidence in patients overage 60
· may reflect inadequate immunisation
· in Britain, 15 cases / year and in USA, 100 cases / year
· organism
· anaerobic
· spore-bearing
· Gram-positive bacillus
· spores
· terminal (drumstick appearance)
· found in faeces, dust and soil
· esp. in hot damp climates
· esp. in soils rich with organic matter (esp. horse manure)
· resistant to antiseptics and heat (autoclaving for 10 min is satisfactory)
· Cl tetani is non-invasive
· infection only occurs when spores enter tissues and produce vegetative forms
· usual mode of entry through puncture wound or laceration
· injury may be trivial
· no history or evidence of wound in 20%
· germination of spores occurs in oxygen-poor media
· ie. necrotic tissue
· infection remains localised
· spores may enter tissue and lie dormant, reactivated by subsequent injury
· produced by vegetative form
· released with lysis
Tetanospasmin
· exotoxin released when bacteria lysed in wound
· is potent neurotoxin (0.1 mg lethal)
· spreads to CNS through motor nerve or via blood stream and lymphatics
· principal effect is to block inhibitory pathways to spinal cord
· result is that stimuli to CNS are not damped down
· muscle rigidity with paroxysmal spasms or convulsions result
· effects are self-limiting
· no residual effects if recover
Tetanolysin
· another toxin
· is haemolysin
· mean incubation period is 1 week
· varies (2-60 days) but usually < 15 days
· rapid onset = severe disease
· pain and stiffness in
· jaw
· abdomen
· back
· difficulty swallowing
· generalised rigidity
· difficulty opening mouth
· trismus or 'lockjaw'
· characteristic clenched teeth expression
· risus sardonicus
· spinal extension and neck retraction
· upper limb flexion and lower limb extension
· reflex spasms
· triggered by external stimuli (eg. noise, pressure)
· glottic and laryngeal spasms may cause cardio-respiratory arrest
· sympathetic dysfunction
· hypertension, tachycardia, sweating, arrhythmias, paralytic ileus
· muscle spasms disappear after 1-3 weeks
· most survivors recover completely after 6 weeks
· death usually occurs within 2 weeks
· respiratory complications are the major cause of death
· hypoxia, asphyxia or cardiorespiratory arrest
· aspiration
· pneumonia
· no specific laboratory tests
· Cl tetani cultured from wound in 1/3 of cases
Tetanus vaccine
· use tetanus toxin rendered non-toxic by action of formalin
· tetanus vaccines available
· TT (tetanus toxoid)
· triple antigen (diphtheria-tetanus-pertussis)
· CDT (child diphtheria-tetanus)
· ADT (adult diphtheria-tetanus)
· immunity conferred offers no immediate protection in unimmunised
· production of antibodies (antitoxins) by patient takes several weeks
· effects are long-lasting
Primary immunisation regimen (children)
· Triple Antigen at 2, 4 and 6 months
· CDT at 18 months and 5 years
Adult immunisation regimen
· only for those never immunised
· 3 courses of TT
· 6-12 week interval between 1st and 2nd
· 6-12 month interval between 2nd and 3rd
Booster
· ADT booster every 10 years
· if more than 20 years since booster, 2 boosters with 4-6 week interval
After injury
· if immunised, single booster injection will produce protective antibodies in one day
Types of wounds
· non-tetanus-prone wounds
· clean
· non-penetrating
· little tissue damage
· less than 6 hours old
· tetanus-prone wound
· open fracture
· puncture wound
· foreign body
· contamination
· extensive tissue damage
· more than 6 hours old
· septic wound
· animal bite
Tetanus toxoid boosters
· if patient not immune
· full TT course
· if wound not tetanus-prone and patient immune
· if < 10 years since booster, no TT
· if 10-20 years since booster, single TT
· if > 20 years since booster, two TT (separated by 4-6 weeks)
· if wound tetanus-prone and patient immune
· if < 2 years since booster, no TT
· if 2-20 years since booster, single TT
· if > 20 years since booster, two TT (separated by 4-6 weeks)
· TIG (tetanus immunoglobulin)
· solution of gamma-globulin fraction of donated plasma
· give in tetanus-prone wounds
· if not immune
· if immune and > 10 years since booster
· dose is 250 mg IM
· into different limb from TT
· debridement of necrotic and contaminated tissue
· tetanus spores destroyed by antibiotics
· vegetative form sensitive to antibiotics
· use penicillin G
· 2 million units q6h for 10 days
· a more concentrated TIG for treating clinical tetanus
· neutralises circulating toxin
· does not affect toxins already fixed in CNS
· control of spasms
· quiet dark room
· IV diazepam
· consider thiopental infusion
· care of airway
· ET tube and ventilation with severe spasms or respiratory failure
· tracheostomy
· hydration and nutrition
· autonomic dysfunction
· depends on
· rapidity of onset
· severity of attack
· mortality rate is 60%